microRNA expression patterns across seven cancers are highly correlated and dominated by evolutionarily ancient families

por DEVOR, ERIC J., SCHICKLING, BRANDON M., LESLIE, KIMBERLY K.
Publicado 2014

An inhibitor of K(+ )channels modulates human endometrial tumor-initiating cells

por Schickling, Brandon M, Aykin-Burns, Nukhet, Leslie, Kimberly K, Spitz, Douglas R, Korovkina, Victoria P
Publicado 2011

The Synthetic Curcumin Analog HO-3867 Rescues Suppression of PLAC1 Expression in Ovarian Cancer Cells

por Devor, Eric J., Schickling, Brandon M., Lapierre, Jace R., Bender, David P., Gonzalez-Bosquet, Jesus, Leslie, Kimberly K.
Publicado 2021

BKCa channel inhibitor modulates the tumorigenic ability of hormone-independent breast cancer cells via the Wnt pathway

por SCHICKLING, BRANDON M., ENGLAND, SARAH K., AYKIN-BURNS, NUKHET, NORIAN, LYSE A., LESLIE, KIMBERLY K., FRIEDEN-KOROVKINA, VICTORIA P.
Publicado 2015

Cullin-5, a ubiquitin ligase scaffold protein, is significantly underexpressed in endometrial adenocarcinomas and is a target of miR-182

por DEVOR, ERIC J., SCHICKLING, BRANDON M., REYES, HENRY D., WARRIER, AKSHAYA, LINDSAY, BRITTANY, GOODHEART, MICHAEL J., SANTILLAN, DONNA A., LESLIE, KIMBERLY K.
Publicado 2016

p53 mutation status is a primary determinant of placenta-specific protein 1 expression in serous ovarian cancers

por Devor, Eric J., Gonzalez-Bosquet, Jesus, Warrier, Akshaya, Reyes, Henry D., Ibik, Nonye V., Schickling, Brandon M., Newtson, Andreea, Goodheart, Michael J., Leslie, Kimberly K.
Publicado 2017